The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0281
Abstract: Despite the availability of multiple treatment options, the prognosis for advanced gastric cancer (AGC) remains poor and more effective treatment options are needed. Ramucirumab is an established and recommended second-line treatment for AGC. In recently… read more here.
Keywords: containing regimens; advanced gastric; gastric cancer; clinical position ... See more keywords